Source: Health Canada shortage reports · Updated Jul 27, 2026
Some Indocyanine Green products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A diagnostic dye used in imaging to assess blood flow and liver function.
Products affected
1 / 3
In shortage since
Dec 1, 2019
Reports on file
8
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
IC-GREEN
25MG · POWDER · AKORN INC
DIN 02014793 · since Dec 1, 2019, no end estimate · Disruption of the manufacture of the drug.
Resolved
INDOCYANINE GREEN FOR INJECTION, USP
25MG · POWDER FOR SOLUTION · DIAGNOSTIC GREEN LIMITED
DIN 02485796 · ended Feb 19, 2025 · Disruption of the manufacture of the drug.
Resolved
INDOCYANINE GREEN FOR INJECTION KIT
25MG · KIT
POWDER FOR SOLUTION · DIAGNOSTIC GREEN GMBH
DIN 02485826 · ended May 3, 2021 · Shortage of an inactive ingredient or component.
Discontinued
IC-GREEN
25MG · POWDER · AKORN INC
DIN 02014793
Resolved
IC-GREEN
25MG · POWDER · AKORN INC
DIN 02014793 · ended Feb 25, 2019 · Disruption of the manufacture of the drug.
Resolved
IC-GREEN
25MG · POWDER · AKORN INC
DIN 02014793 · ended Mar 21, 2018 · Manufacturer has insufficient capacity to meet demand.
Resolved
IC-GREEN
25MG · POWDER · AKORN INC
DIN 02014793 · ended Feb 5, 2018 · Disruption of the manufacture of the drug.
Resolved
IC-GREEN
25MG · POWDER · AKORN INC
DIN 02014793 · ended Aug 31, 2017 · Disruption of the manufacture of the drug.
What's happening
Indocyanine Green is currently affected by an active shortage report filed with Health Canada by AKORN INC.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Indocyanine Green is classified under “OTHER DIAGNOSTIC AGENTS” (ATC V04CX).
Recent changes
No changes recorded yet.
Common questions
What is Indocyanine Green used for?
A diagnostic dye used in imaging to assess blood flow and liver function.
When will Indocyanine Green be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Indocyanine Green in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.